Alerce Investment Management’s Assembly Biosciences ASMB Stock Holding History

Alerce Investment Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-185,625	Closed	-$1.97M	–	6
2023 Q3	$1.97M	Hold	185,625	–	–	3.37%	5
2023 Q2	$2.56M	Hold	185,625	–	–	3.33%	5
2023 Q1	$1.87M	Hold	185,625	–	–	2.47%	5
2022 Q4	$2.9M	Hold	185,625	–	–	3.33%	5
2022 Q3	$3.65M	Hold	185,625	–	–	3.52%	5
2022 Q2	$4.68M	Hold	185,625	–	–	8.68%	3
2022 Q1	$4.59M	Hold	185,625	–	–	7.77%	5
2021 Q4	$5.19M	Hold	185,625	–	–	5.28%	6
2021 Q3	$7.75M	Hold	185,625	–	–	5.31%	6
2021 Q2	$8.64M	Hold	185,625	–	–	4.69%	6
2021 Q1	$10.2M	Hold	185,625	–	–	4.53%	5
2020 Q4	$13.5M	Buy	+185,625	New	+$21.8M	5.31%	3

Other funds holding ASMB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Acuitas Investments Seattle, Washington $1.43M AUM 17.52% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Alerce Investment Management's ASMB Position: Q4 2023 in Review

Alerce Investment Management sold out of Assembly Biosciences (ASMB) in Q4 2023, closing a stake of 185,625 shares — an estimated $1.97M sold.

Alerce Investment Management first reported a position in ASMB in Q4 2020 and held it in 12 quarters. The position peaked at $13.5M in Q4 2020. 44 funds tracked by Wall St. Rank hold ASMB as of Q4 2023.

Alerce Investment Management reported no remaining Assembly Biosciences position as of Q4 2023 after selling out during the quarter.
Alerce Investment Management sold 185,625 Assembly Biosciences shares in Q4 2023, an estimated $1.97M.
Alerce Investment Management first reported a position in Assembly Biosciences in Q4 2020 and held it in 12 quarters.
Alerce Investment Management's Assembly Biosciences position peaked at $13.5M in Q4 2020.
44 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2023.

Based on Alerce Investment Management's 13F filing for Q4 2023, filed 9 Feb 2024.